Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma

BACKGROUND: In this study, we investigated the contribution of a gene expression–based signature (composed of BAG1, BRCA1, CDC6, CDK2AP1, ERBB3, FUT3, IL11, LCK, RND3, SH3BGR) to survival prediction for early-stage lung adenocarcinoma categorized by the new International Association for the Study of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yifeng, Hou, Likun, Yang, Yu, Xie, Huikang, Yang, Yang, Li, Zhigang, Zhao, Heng, Gao, Wen, Su, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966694/
https://www.ncbi.nlm.nih.gov/pubmed/27524912
http://dx.doi.org/10.2147/OTT.S107272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966694/
https://www.ncbi.nlm.nih.gov/pubmed/27524912
http://dx.doi.org/10.2147/OTT.S107272

Ejemplares similares